189 related articles for article (PubMed ID: 38594611)
21. Distinct patterns of primary and motile cilia in Rathke's cleft cysts and craniopharyngioma subtypes.
Coy S; Du Z; Sheu SH; Woo T; Rodriguez FJ; Kieran MW; Santagata S
Mod Pathol; 2016 Dec; 29(12):1446-1459. PubMed ID: 27562488
[TBL] [Abstract][Full Text] [Related]
22. Adamantinomatous craniopharyngioma: moving toward targeted therapies.
Hengartner AC; Prince E; Vijmasi T; Hankinson TC
Neurosurg Focus; 2020 Jan; 48(1):E7. PubMed ID: 31896087
[TBL] [Abstract][Full Text] [Related]
23. Identification and Functional Enrichment Analysis of Potential Diagnostic and Therapeutic Targets in Adamantinomatous Craniopharyngioma.
Zou YF; Meng LB; Wang QQ; He ZK; Hu CH; Shan MJ; Wang DY; Yu X
J Comput Biol; 2020 Jan; 27(1):55-68. PubMed ID: 31424286
[TBL] [Abstract][Full Text] [Related]
24. Integrative Analysis of Biomarkers and Mechanisms in Adamantinomatous Craniopharyngioma.
Lin D; Zhao W; Yang J; Wang H; Zhang H
Front Genet; 2022; 13():830793. PubMed ID: 35432485
[TBL] [Abstract][Full Text] [Related]
25. Adamantinomatous craniopharyngioma associated with a compromised blood-brain barrier: patient series.
Prince EW; Hoffman LM; Vijmasi T; Dorris K; McWilliams JA; Jordan KR; Mirsky DM; Hankinson TC
J Neurosurg Case Lessons; 2021 May; 1(19):CASE2150. PubMed ID: 35854837
[TBL] [Abstract][Full Text] [Related]
26. CBX4-dependent regulation of HDAC3 nuclear translocation reduces Bmp2-induced osteoblastic differentiation and calcification in adamantinomatous craniopharyngioma.
Yan X; Kang D; Lin Y; Qi S; Jiang C
Cell Commun Signal; 2022 Jan; 20(1):3. PubMed ID: 34980138
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiles reveal key genes for early diagnosis and treatment of adamantinomatous craniopharyngioma.
Yang J; Hou Z; Wang C; Wang H; Zhang H
Cancer Gene Ther; 2018 Oct; 25(9-10):227-239. PubMed ID: 29681617
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional analyses of adult and pediatric adamantinomatous craniopharyngioma reveals similar expression signatures regarding potential therapeutic targets.
Prince E; Whelan R; Donson A; Staulcup S; Hengartner A; Vijmasi T; Agwu C; Lillehei KO; Foreman NK; Johnston JM; Massimi L; Anderson RCE; Souweidane MM; Naftel RP; Limbrick DD; Grant G; Niazi TN; Dudley R; Kilburn L; Jackson EM; Jallo GI; Ginn K; Smith A; Chern JJ; Lee A; Drapeau A; Krieger MD; Handler MH; Hankinson TC;
Acta Neuropathol Commun; 2020 May; 8(1):68. PubMed ID: 32404202
[TBL] [Abstract][Full Text] [Related]
29. Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma.
Donson AM; Apps J; Griesinger AM; Amani V; Witt DA; Anderson RCE; Niazi TN; Grant G; Souweidane M; Johnston JM; Jackson EM; Kleinschmidt-DeMasters BK; Handler MH; Tan AC; Gore L; Virasami A; Gonzalez-Meljem JM; Jacques TS; Martinez-Barbera JP; Foreman NK; Hankinson TC;
J Neuropathol Exp Neurol; 2017 Sep; 76(9):779-788. PubMed ID: 28859336
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic control of adamantinomatous craniopharyngiomas.
Marrero-Gutiérrez J; Bueno AC; Martins CS; Coeli-Lacchini FB; Silva-Júnior RMP; Marques Gonçalves GH; Ozaki JGO; de Almeida E Silva DC; Wildemberg LE; da Silva Antunes XL; Dos Santos AC; Machado HR; Santos MV; Moreira AC; Gadelha MR; Vêncio RZN; Antonini SRR; de Castro M
J Clin Endocrinol Metab; 2024 Jan; ():. PubMed ID: 38181427
[TBL] [Abstract][Full Text] [Related]
31. Pathology and pathogenesis of craniopharyngiomas.
Larkin SJ; Ansorge O
Pituitary; 2013 Mar; 16(1):9-17. PubMed ID: 22886701
[TBL] [Abstract][Full Text] [Related]
32. A Novel Immune Classification for Predicting Immunotherapy Responsiveness in Patients With Adamantinomatous Craniopharyngioma.
Yuan F; Cai X; Zhu J; Yuan L; Wang Y; Tang C; Cong Z; Ma C
Front Neurol; 2021; 12():704130. PubMed ID: 34966342
[TBL] [Abstract][Full Text] [Related]
33. Do craniopharyngioma molecular signatures correlate with clinical characteristics?
Omay SB; Chen YN; Almeida JP; Ruiz-Treviño AS; Boockvar JA; Stieg PE; Greenfield JP; Souweidane MM; Kacker A; Pisapia DJ; Anand VK; Schwartz TH
J Neurosurg; 2018 May; 128(5):1473-1478. PubMed ID: 28707994
[TBL] [Abstract][Full Text] [Related]
34. Telomere length and Wnt/β-catenin pathway in adamantinomatous craniopharyngiomas.
Mota JIS; Silva-Júnior RMP; Martins CS; Bueno AC; Wildemberg LE; Antunes XLDS; Ozaki JGO; Coeli-Lacchini FB; Garcia-Peral C; Oliveira AER; Santos AC; Moreira AC; Machado HR; Dos Santos MV; Colli LM; Gadelha MR; Antonini SRR; de Castro M
Eur J Endocrinol; 2022 Jun; 187(2):219-230. PubMed ID: 35584004
[TBL] [Abstract][Full Text] [Related]
35. Identification and Characterization of TF-lncRNA Regulatory Networks Involved in the Tumorigenesis and Development of Adamantinomatous Craniopharyngioma.
Xu D; Guo Y; Lei S; Guo A; Song D; Gao Q; Zhao S; Yin K; Wei Q; Zhang L; Wang X; Wang J; Zhang Q; Guo F
Front Oncol; 2021; 11():739714. PubMed ID: 35155179
[TBL] [Abstract][Full Text] [Related]
36. Proteomics in pediatric cystic craniopharyngioma.
Massimi L; Martelli C; Caldarelli M; Castagnola M; Desiderio C
Brain Pathol; 2017 May; 27(3):370-376. PubMed ID: 28414889
[TBL] [Abstract][Full Text] [Related]
37. Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma.
Martinez-Barbera JP
Neuropathol Appl Neurobiol; 2015 Oct; 41(6):721-32. PubMed ID: 25611703
[TBL] [Abstract][Full Text] [Related]
38. Calretinin is expressed in the stroma of adamantinomatous craniopharyngioma and may induce calcification.
Chaohu W; Yi L; Hai H; Hui Z; Jun P; Song-Tao Q
Clin Neurol Neurosurg; 2015 Nov; 138():124-8. PubMed ID: 26319618
[TBL] [Abstract][Full Text] [Related]
39. Sonic Hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas.
Gomes DC; Jamra SA; Leal LF; Colli LM; Campanini ML; Oliveira RS; Martinelli CE; Elias PC; Moreira AC; Machado HR; Saggioro F; Neder L; Castro M; Antonini SR
Eur J Endocrinol; 2015 May; 172(5):603-8. PubMed ID: 25693592
[TBL] [Abstract][Full Text] [Related]
40. Comparison of neuroendocrine dysfunction in patients with adamantinomatous and papillary craniopharyngiomas.
Feng Y; Ni M; Wang YG; Zhong LY
Exp Ther Med; 2019 Jan; 17(1):51-56. PubMed ID: 30651764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
